PDCD1 and neoplasm: Tumor bioluminescence imaging demonstrated that Sono@NAT10 significantly suppressed tumor growth compared to PBS, and its combination with anti‐PD‐1 (CD279) antibody achieved further tumor reduction (Figure 8D; Figure S9A, Supporting Information).